RxDoctor Payments Data
★ My doctorsLook up a doctor →

Hillary Davis, APRN

Family · Jonesboro, ARNPI 1285362913

Payments from drug & device makers

$6,197in general payments, 2019–2025

Across 314 payments — averaging $19.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$774
  • Daiichi Sankyo Inc.$626
  • Novartis$572
  • Merck$421
  • AstraZeneca$391
  • Exelixis Inc.$346
  • plus $3K from 39 others

What the payments were for

  • Food & beverage$5,63591%
  • Education$5629%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson35$774
Daiichi Sankyo Inc.26$626
Novartis38$572
Merck25$421
AstraZeneca19$391
Exelixis Inc.17$346
Incyte Corporation14$296
Takeda Pharmaceuticals U.S.A., Inc.13$280
Eisai Inc.11$235
AbbVie10$194
Pfizer10$172
Regeneron Healthcare Solutions, Inc.8$167
Lilly USA, LLC8$141
Seagen Inc.3$130
GSK8$127
Iovance Biotherapeutics, Inc.5$104
Bayer5$94
Ipsen Biopharmaceuticals, Inc6$91
Deciphera Pharmaceuticals Inc.4$89
Beone Medicines USA, Inc.4$80
G1 Therapeutics, Inc.1$80
AVEO Pharmaceuticals, Inc.4$70
Sanofi3$70
EMD Serono, Inc.3$66
Genentech USA, Inc.4$58
Pharmacosmos Therapeutics Inc.3$55
Pharmaessentia USA Corporation3$53
Kyowa Kirin, Inc.2$46
Beigene USA, Inc.2$33
Amgen2$32
Array Biopharma Inc2$32
Puma Biotechnology, Inc.2$31
Sumitomo Pharma America, Inc.1$30
Caris MPI, Inc.2$29
Tersera Therapeutics LLC1$22
Tempus AI, Inc1$20
Boehringer Ingelheim1$20
Azurity Pharmaceuticals, Inc.1$18
E.r. Squibb & Sons, L.L.C.1$18
Alnylam Pharmaceuticals Inc.1$15
Acrotech Biopharma Inc.1$15
Geron Corporation1$15
Sobi, Inc1$15
Syndax Pharmaceuticals, Inc.1$14
Rigel Pharmaceuticals, Inc.1$8

How this compares

$6,197 in reported general payments places this provider in the 95th percentile of 2,103 family providers in Arkansas.

See all family providers in Arkansas →

Medicare billing

Part B allowed, 2024
$2,039
Medicare patients
72
Services billed
75

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Jonesboro

See the full list for Arkansas →

Where these figures come from

Is this you, or does something look wrong? →